Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

W. Serruys, Patrick; Silber, Sigmund; Garg, Scot; van Geuns, Robert‐Jan; Richardt, Gert; Buszman, Paweł; Kelbæk, Henning; J. van Boven, Adrianus; H. Hofma, Sjoerd; Linke, Axel; Klauß, Volker; Wijns, William; Macaya, Carlos; Garot, Philippe; Di Mario, Carlo; Manoharan, Ganesh; Kornowski, Ran; Ischinger, Thomas; L. Bartorelli, Antonio; E. Ronden, Jacintha; Bressers, Marco; Gobbens, Pierre; Negoita, Manuela; N. van Leeuwen, Frank; Windecker, Stephan

doi:10.1056/nejmoa1004130

Public

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

Published in New England Journal of Medicine • Jun 17, 2010

Authors:

Patrick W. Serruys

Sigmund Silber

Scot Garg

Abstract

BACKGROUND: New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorse...

Subject

Zotarolimus

Medicine

Stent

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!